Hypocomplementemia during tocilizumab treatment

Hypocomplementemia during tocilizumab treatment

Abstract. Hypocomplementemia has been reported in patients with rheumatoid arthritis treated with tocilizumab (TCZ), but its long-term consequences are unknown. We assessed the long-term outcome of patients treated with TCZ who developed hypocomplementemia regarding serious bacterial infections or a...

Full description

Bibliographic Details
Main Authors: Amir Bieber, MD, Doron Markovits, MD, PhD, Kohava Toledano, MD, Yonit Tavor, MD, Reuven Mader, MD, Alexandra Balbir-Gurman, MD, Yolanda Braun-Moscovici, MD
Format: Article
Language:English
Published: Wolters Kluwer 2022-06-01
Series:Medicine
Online Access:http://journals.lww.com/10.1097/MD.0000000000029528

Internet

http://journals.lww.com/10.1097/MD.0000000000029528

Similar Items